INGN Stock Analysis: Buy, Sell, or Hold?
INGN - Inogen Inc
$6.11
-0.08 (-1.29%)
▼
5d:
-5.27%
30d:
+0.16%
90d:
-10.15%
HOLD
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 06, 2026
Get Alerted When INGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: INGN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: INGN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: INGN is currently trading at $6.11, which is considered fair relative to its 30-day fair value range of $5.99 to $6.40. From a valuation perspective, the stock is trading at a discount (Forward PE: -19.7) compared to its historical average (120.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, INGN is in a downtrend. The price is currently testing key support at $6.02. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.00 (+112.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INGN is in a downtrend. The price is currently testing key support at $6.02. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.00 (+112.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$5.99 -
$6.40
Company Quality Score
56/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
75.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 112.8% below Wall St target ($13.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Recommendation downgraded due to -5.3% 5-day decline
Fair Price Analysis
30-Day Fair Range
$5.99 -
$6.40
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$0.56
(9.2%)
Support & Resistance Levels
Support Level
$6.02
Resistance Level
$6.66
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-19.71
Wall Street Target
$13.00
(+112.8%)
Revenue Growth (YoY)
2.0%
Earnings Growth (YoY)
87.3%
Profit Margin
-6.5%
PE vs Historical
-19.7 vs 120.2
CHEAP
Share & Embed Analysis
Last updated: March 31, 2026 3:41 AM ET
Data refreshes hourly during market hours. Next update: 4:41 AM
Data refreshes hourly during market hours. Next update: 4:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 61 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 50 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$93 | 59 HOLD |
